Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

McKesson
Moodys
Johnson and Johnson
Express Scripts
Dow
Medtronic

Last Updated: December 8, 2019

DrugPatentWatch Database Preview

Litigation Details for Amgen Inc. v. Apotex Inc (S.D. Fla. 2018)

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

Amgen Inc. v. Apotex Inc (S.D. Fla. 2018)

Docket   Start Trial Date Filed 2018-08-07
Court District Court, S.D. Florida Date Terminated
Cause 35:0271 Patent Infringement Assigned To William P. Dimitrouleas
Jury Demand None Referred To Lurana S. Snow
Parties AMGEN INC.; AMGEN MANUFACTURING LIMITED; APOTEX CORP.; APOTEX INC
Patents 5,824,784
Attorneys Aaron J. Marks; Aaron S. Lukas; Barry P. Golob; Eric Agovino; Golda Lai; Jacob T. Whitt; Jason David Sternberg; Jennifer Gordon; Jennifer H. Wu; John F. O'Sullivan; Keri L. Schaubert; Kerry B. McTigue; Naz E. Wehrli; Nicholas Groombridge; Paige Spencer Comparato; Paula Fritsch; Simeon Daniel Brier; Stephen A. Maniscalco; W. Blake Coblentz
Firms Aaron S. Lukas; Amgen Inc; Barry P. Golob; Hogan Lovells US LLP; Keri L. Schaubert; Kerry B. McTigue; Paul Weiss Rifkind Wharton & Garrison, LLP; Paul, Weiss, Rifkind, Wharton & Garrison LLP; Paul, Weiss, Rifkind, Wharton Z& Garrison, LLP; W. Blake Coblentz
Link to Docket External link to docket
Biologic Drugs cited in Amgen Inc. v. Apotex Inc
The biologic drug covered by the patent cited in this case is   Start Trial .

Details for Amgen Inc. v. Apotex Inc (S.D. Fla. 2018)

Date Filed Document No. Description Snippet Link To Document
0000-00-00 1 and U.S. Patent No. 5,824,784 (“the ’784 Patent”). See No. 0:15-cv-61631- JIC, D.E. 1 at 2 (S.D. Fla.…action for patent infringement involving United States Patent No. 9,856,287 (“the ’287 Patent”), attached…identified [United States Patent No. 8,952,138 (“the ’138 Patent”)] as a patent that the Apotex-proposed… ’138 Patent. Amgen also identified and asserted U.S. Patent No. 6,162,427 (“the ’427 Patent”) and … prior patent infringement actions, the U.S. Patent and Trademark Office issued the ’287 Patent to External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Harvard Business School
McKesson
AstraZeneca
Johnson and Johnson
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.